Crenolanib is a selective type I pan-FLT3 inhibitorCatherine C. Smith, Neil P. Shah, Elisabeth A. Lasater et al.|Proceedings of the National Academy of Sciences|2014Cited by 211
Clinical Utility of Next-Generation Sequencing for Oncogenic Mutations in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell TransplantationMarlise R. Luskin, Ran Reshef, Jianhua Zhao et al.|Biology of Blood and Marrow Transplantation|2016Cited by 38
Eltrombopag Modulates Reactive Oxygen Species and Decreases Acute Myeloid Leukemia Cell SurvivalAnna Kalota, Martin Carroll|PLoS ONE|2015Cited by 36